From sea to seed: A comparability study of animal-derived squalene with PhytoSquene® plant-based squalene in adjuvant formulations

PhytoSquene^® is a plant-based squalene developed by Evonik for use in pharmaceutical applications such as vaccine adjuvants. As the world’s first plant-based squalene available in GMP quality, PhytoSquene^® offers pharmaceutical companies the opportunity to improve the safety and sustainability of their products.

In this webinar, our experts present data from a study that compares the physical chemical attributes and in vitro toxicity effects of GMP-grade PhytoSquene^® with animal-derived squalene.

In this webinar you will learn about:

• Squalene and its applications in vaccine adjuvants
• The challenges with using shark-derived squalene
• Comparability studies showing that PhytoSquene^® matches the performance of animal-derived squalene